hide
Free keywords:
Age Factors
Antineoplastic Combined Chemotherapy Protocols/adverse effects/*therapeutic use
Heart Failure/etiology
Hodgkin Disease/diagnosis/*drug therapy
Humans
Survival Rate
Abstract:
Cancer in the adolescent and young adult (AYA) is the second leading cause of nonaccidental death with hematological malignancies spiking during this period. Treatment of AYAs with hematological malignancies usually follows either pediatric or adult protocols with sufficient information lacking on subgroup analyses regarding course and outcome. In this review we will outline up-to-date treatment possibilities for AYAs diagnosed with Hodgkin's lymphoma. Early and late toxicities will be addressed and future directions of research suggested.
